Zhen Zeng
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 5%
- Immune Cell Function and Interaction
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
Papers in
- Hepatology 20
- Hepatocellular Carcinoma Treatment and Prognosis 14
- Liver physiology and pathology 4
- Oncology 22
- Cancer Immunotherapy and Biomarkers 9
- Journals
- Modern Rheumatology (5 papers)Journal of Clinical Oncology (4 papers)Scientific Reports (2 papers)Clinical Rheumatology (2 papers)Hepatology (2 papers)
- Partner nations
- ChinaUnited StatesIsrael
In The Last Decade
Zhen Zeng
71 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 115
- Hepatology 513
- Immunology 560
- Oncology 624
- Rheumatology 301
- Cancer Research 220
Countries citing papers authored by Zhen Zeng
This map shows the geographic impact of Zhen Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Zeng more than expected).
Fields of papers citing papers by Zhen Zeng
This network shows the impact of papers produced by Zhen Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Zeng. The network helps show where Zhen Zeng may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhen Zeng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 16 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 4 | |
| 10 | 2021 | 9 | |
| 11 | 2019 | 3 | |
| 12 | 2017 | 26 | |
| 13 | 2016 | 4 | |
| 14 | 2013 | 13 | |
| 15 | 2012 | 30 | |
| 16 | 2012 | 13 | |
| 17 | 2010 | 371 | |
| 18 | 2010 | 188 | |
| 19 | 2010 | 15 | |
| 20 | The protective effect of echinacoside on acute liver injury in rats | 2008 | 5 |
About Zhen Zeng
Zhen Zeng is a scholar working on Hepatology, Oncology, Immunology, Rheumatology and Cancer Research, having authored 77 papers that have together received 2.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (14 papers), Cancer Immunotherapy and Biomarkers (9 papers), Liver Disease Diagnosis and Treatment (9 papers), Spondyloarthritis Studies and Treatments (6 papers), Ferroptosis and cancer prognosis (5 papers), Hepatitis B Virus Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Hepatology (513 citations), Immunology (560 citations), Oncology (624 citations), Rheumatology (301 citations) and Cancer Research (220 citations). Zhen Zeng has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Yongping Yang, Fu‐Sheng Wang, Ruizhao Qi, Po Tien, Feng Shi, Ming Shi, Ji‐Yuan Zhang, Yinying Lu, Yingchuan Li and Shengqian Xu. Their work appears in journals such as Modern Rheumatology, Journal of Clinical Oncology, Scientific Reports, Clinical Rheumatology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.